Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase NA 1Phase 1 1

Status

Recruiting 2Completed 2Terminated 1

Sponsor Class

OTHER 5INDUSTRY 1

Study Type

Interventional 5

Sponsor

Cancer Type

Gynecologic 5Gastrointestinal 2

Conditions

Breast Neoplasms 272Carcinoma, Non-Small-Cell Lung 195Prostatic Neoplasms 171Stomach Neoplasms 100Lung Neoplasms 93Squamous Cell Carcinoma of Head and Neck 74Head and Neck Neoplasms 69Esophageal Neoplasms 56Neoplasms 47Neoplasm Metastasis 36Pancreatic Neoplasms 31Nasopharyngeal Carcinoma 30Ovarian Neoplasms 27Sarcoma 26Urinary Bladder Neoplasms 25Triple Negative Breast Neoplasms 20Adenocarcinoma 19Carcinoma, Squamous Cell 17Adenocarcinoma Of Esophagus 17Esophageal Squamous Cell Carcinoma 16Carcinoma, Ovarian Epithelial 15Unspecified Adult Solid Tumor, Protocol Specific 13Carcinoma, Transitional Cell 13Breast Neoplasms, Male 13Adenocarcinoma of Lung 12Salivary Gland Neoplasms 11Laryngeal Neoplasms 11Small Cell Lung Carcinoma 10Inflammatory Breast Neoplasms 10Uterine Cervical Neoplasms 9

Interventions

Hyperthermic Intraperitoneal Chemotherapy 27Cisplatin 17Oxaliplatin 16Cytoreduction Surgical Procedures 15Paclitaxel 12Fluorouracil 10Mitomycin 8Leucovorin 8Doxorubicin 7Docetaxel 5Neoadjuvant Therapy 4Blood Specimen Collection 4Taxes 3Surgical Procedures, Operative 3Chemotherapy, Adjuvant 3Carboplatin 3Bevacizumab 3catumaxomab 2Platinum 2Palliative Care 2Observation 2Nivolumab 2Mitozytrex 2Laparoscopy 2Interviews as Topic 2Indocyanine Green 2Folfox protocol 2Albumin-Bound Paclitaxel 21,2-diaminocyclohexaneplatinum II citrate 2tremelimumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
OTHER × Peritoneal Neoplasms × Docetaxel × Clear all
NCT04583488 2024-08-09

Intraperitoneal Docetaxel in Combination With mFOLFOX6 for Gastric Cancer Patients With Peritoneal Carcinomatosis

Johns Hopkins University

Phase 1 Terminated
2 enrolled
GastrointestinalGynecologic

Peritoneal Neoplasms, Stomach Neoplasms

NCT04840264 2024-03-18

Docetaxel, Oxaliplatin and 5-FU for Gastric Cancer With Inoperable Malignant Bowel Obstruction

Sixth Affiliated Hospital, Sun Yat-sen University

Phase 2 Recruiting
79 enrolled
Gynecologic

Peritoneal Neoplasms

NCT04595929 2020-11-25

GASPACCO

St. Petersburg State Pavlov Medical University

Phase NA Recruiting
304 enrolled
GastrointestinalGynecologic

Peritoneal Neoplasms, Stomach Neoplasms

NCT01504256 2018-01-23

CatuNeo

AIO-Studien-gGmbH

Phase 2 Completed
42 enrolled
Gynecologic

Adenocarcinoma, Peritoneal Neoplasms

NCT00183794 2014-05-22

Clinical Trial of Docetaxel in Combination With Gemcitabine in Platinum-Resistant Ovarian Cancer and Primary Peritoneal Carcinoma

University of Southern California

Phase 2 Completed
20 enrolled 8 charts
Gynecologic

Ovarian Neoplasms, Peritoneal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡